NuvOx Pharma Presents at AZ BIO White Hat Event
- Oct 11, 2022
- 0 min read
top of page
Search
Recent Posts
See AllTucson, AZ –March 4, 2026, NuvOx Therapeutics, Inc. (“NuvOx”) today announced that the U.S. Food and Drug Administration (FDA) has authorized NuvOx to proceed with a new Phase II clinical trial evalu
Tucson, AZ –December 15, 2025, NuvOx Therapeutics, Inc. (“NuvOx”) announced that the first patient has been enrolled in the Phase IIb NOVEL trial (NanO 2 in Large Vessel Occlusion Stroke (NOVEL): a
Tucson, AZ – November 24, 2025 – Today NuvOx Therapeutics, Inc. (“NuvOx”) along with Dr. Pavani Chalasani of George Washington University announced the acceptance of abstracts in Triple Negative Bre
bottom of page
Comments